This document discusses minimal hepatic encephalopathy (MHE), which can cause subtle cognitive changes. Several neuropsychological tests are mentioned that can detect selective attention, visuospatial abilities, fine motor skills, and memory impairments in MHE patients. Ammonia is identified as the most important central nervous system neurotransmitter involved in MHE, affecting the GABA and benzodiazepine systems among others. MHE is graded on a scale from 0-4 based on severity of symptoms from normal to stupor and coma. Magnetic resonance spectroscopy can show brain metabolic changes in MHE patients that improve after liver transplantation.